Marye Gleva

Medicine & Life Sciences

1. Implantable Defibrillators 100%
2. Defibrillators 69%
3. Cardiac Resynchronization Therapy 41%
4. Shock 31%
5. Equipment and Supplies 30%
6. Lead 27%
7. Tachycardia 27%
8. Cardiomyopathies 24%
9. Registries 23%
10. Ventricular Tachycardia 21%
11. Ventricular Fibrillation 20%
12. Atrial Fibrillation 20%
13. Primary Prevention 20%
14. Maze Procedure 19%
15. Anti-Arrhythmia Agents 17%
16. Heart Diseases 16%
17. Lasers 14%
18. Cardiac Arrhythmias 14%
19. Heart Failure 13%
20. Electrocardiography 11%
21. Left Ventricular Function 11%
22. Mortality 10%
23. Catheter Ablation 10%
24. Infections 9%
25. Safety 9%
26. Heart 9%
27. Recurrence 9%
28. Survival 8%
29. Atrioventricular Nodal Reentry Tachycardia 8%
30. Confidence Intervals 7%
31. Magnetic Resonance Imaging 7%
32. Electrodes 7%
33. Sudden Cardiac Death 7%
34. Radiofrequency Ablation 7%
35. Ventricular Remodeling 6%
36. Sudden Death 6%
37. Hypertrophic Cardiomyopathy 6%
38. Ambulatory Electrocardiography 6%
39. Stroke Volume 6%
40. Syncope 6%
41. Therapeutics 6%
42. Chronic Renal Insufficiency 5%
43. Clinical Protocols 5%
44. Anti-Bacterial Agents 5%
45. Sepsis 5%
46. Head 5%